Celularity Inc. CELU
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.85M | 4.10M | 5.28M | 5.74M | 11.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.85M | 4.10M | 5.28M | 5.74M | 11.43M |
| Cost of Revenue | 1.45M | 7.37M | 3.90M | 5.24M | 3.55M |
| Gross Profit | 2.39M | -3.27M | 1.38M | 494.00K | 7.87M |
| SG&A Expenses | 9.17M | 15.06M | 9.31M | 12.63M | 14.26M |
| Depreciation & Amortization | 368.00K | -1.48M | 325.00K | 372.00K | 368.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.98M | 24.30M | 18.13M | 21.60M | 21.91M |
| Operating Income | -10.13M | -20.20M | -12.85M | -15.86M | -10.49M |
| Income Before Tax | 874.00K | -24.36M | -23.08M | -24.52M | -19.75M |
| Income Tax Expenses | -- | 3.00K | -- | -- | -- |
| Earnings from Continuing Operations | 874.00K | -24.36M | -23.08M | -24.52M | -19.75M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 874.00K | -24.36M | -23.08M | -24.52M | -19.75M |
| EBIT | -10.13M | -20.20M | -12.85M | -15.86M | -10.49M |
| EBITDA | -8.54M | -18.85M | -11.08M | -14.03M | -8.65M |
| EPS Basic | 0.02 | -0.86 | -0.88 | -1.02 | -0.84 |
| Normalized Basic EPS | 0.02 | -0.42 | -0.54 | -0.61 | -0.37 |
| EPS Diluted | 0.02 | -0.86 | -0.88 | -1.02 | -0.84 |
| Normalized Diluted EPS | 0.02 | -0.42 | -0.54 | -0.61 | -0.37 |
| Average Basic Shares Outstanding | 29.07M | 28.45M | 26.35M | 24.02M | 23.53M |
| Average Diluted Shares Outstanding | 30.30M | 28.45M | 26.35M | 24.02M | 23.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |